Electromedical Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Electromedical Technologies generated cash of -$1,417,393, which is less than the previous year. Cash used in financing activities reached the amount of -$608,211 last year. Net change in cash is therefore -$280,721.
Cash Flow
| 2017 | -137.92K | 0 | 20.87K |
|---|---|---|---|
| 2019 | -280.77K | 0 | 280.77K |
| 2020 | -1.33M | 0 | 1.60M |
| 2021 | -1.19M | 0 | 1.31M |
| 2022 | -773.33K | 0 | 758.59K |
| 2023 | -1.41M | 1.74M | -608.21K |
EMED Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 368.42K | 383.17K | 264.91K | 0 | 0 | 144.91K |
Operating activities | ||||||
Net income | -2.64M | -3.46M | -8.48M | -3.87M | -1.74M | -510.41K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 26.20K | 21.87K | 21.87K | 21.87K | 24.45K | 22.58K |
Stock-based compensation expense | 715K | 509.60K | 2.63M | 2.22M | 801.28K | 0 |
| Deferred income tax benefit | 715K | 509.60K | 2.63M | 2.22M | 801.28K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 3.2K | 25.64K | -17.39K | -5.79K | -1.89K | -2.87K |
Inventories | -6.45K | 156.44K | -139.79K | -54.01K | 564.76K | -11.72K |
Accounts payable | -27.26K | 51.95K | -40.52K | 11.45K | 84.18K | 0 |
Cash generated by operating activities | -1.41M | -773.33K | -1.19M | -1.33M | -280.77K | -137.92K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -149.70K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 1.74M | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 42.76K | 0 | 13.56K | 110K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -24K |
Repurchases of common stock | 0 | 0 | 0 | -36.43K | 0 | 0 |
Repayments of term debt | -608.38K | 715.82K | -198.05K | -65.59K | 170.77K | 68.70K |
Cash used in financing activities | -608.21K | 758.59K | 1.31M | 1.60M | 280.77K | 20.87K |
Net Change In Cash | -280.72K | -14.74K | 118.25K | 264.91K | 0 | -117.05K |
Cash at end of period | 87.70K | 368.42K | 383.17K | 264.91K | 0 | 27.86K |
| Data source | Data source | Data source | Data source |